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Background: Pulmonary hypertension (PH) may arise from both pre-capillary and post-capillary etiologies. The impact of PH etiology upon post-
procedural management and outcomes after transcatheter aortic valve replacement (TAVR) is unknown.
methods: We compared post-procedural management and outcomes after TAVR by the European Society of Cardiology PH classification 
among 196 consecutive patients at a single center from 4/2009 - 4/2013: 1) No PH (mean pulmonary artery pressures (mPA) <25 mm Hg); 2) 
pre-capillary PH (mPA≥25 and pulmonary capillary wedge pressure (PCWP) <15 mm HG; 3) post-capillary passive PH (mPA≥25, PCWP≥15 and 
transpulmonary gradient (TPG) ≤12), and 4) post-capillary reactive PH (mPA≥25, PCWP>15 and TPG>12).
Results: 168 patients had sufficient quality data to classify PH etiology (age = 85±9, 55% women). Baseline characteristics did not differ between 
groups except for PA mean and LVEF (Table). After TAVR, post-capillary reactive PH patients were more likely to require pressors, iloprost and 
sildenafil; post-capillary PH patients had higher 1-year mortality (29%, p=0.03). In Cox proportional hazards analysis, all-cause mortality significantly 
differed by PH subtype after adjustment for PA mean and LVEF.
conclusion: Patients with different types of PH undergoing TAVR have significantly different PA pressures, LVEF, pressor requirements and 1-year 
mortality. Advanced PH therapies are only occasionally required among patients with post-capillary reactive PH. 
